QA: Viracta Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001061027_2019_Viracta_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001061027, Viracta Therapeutics Inc

  xvar xval
0 AssetsCurrent 15,200,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 11,000
3 remainder_Assets 113,000
4 LiabilitiesCurrent 11,323,000
5 LiabilitiesNoncurrent 8,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,348,796
9 ResearchAndDevelopmentExpense 11,786,683
10 remainder_Expenses 1,122,393
11 remainder_Revenues 307,323
12 remainder_NetIncome 286,919
13 remainder_ComprehensiveNetIncome 8,916
  yvar yval
0 Assets 15,324,000
1 Liabilities 11,331,000
2 Expenses 24,257,872
3 Revenues 307,323
4 StockholdersEquity 3,993,000
5 NetIncome -23,663,630
6 ComprehensiveNetIncome -23,659,172
7 BaseVar 25,758,015
8 EconomicCapitalRatiobeforeLimitedLiability -1.12
9 EconomicCapitalRatio 1.28

Edgar->Model Mapping

Feature Distribution

Change over Time